Press Releases in 2011

Novus Biologicals announced today a new NODAL antibody (catalog number NBP1-71686) for the study of cancer, angiogenesis and stem cells. This NODAL antibody was made using SDIX Genomic Antibodies^TM (GAT^TM). 

This NODAL Antibody (NBP1-71686) serves as an excellent tool for studying stem cell signaling and as a marker for cancer research.

Novus Biologicals announced today a new line of ChromataChIP^TM kits for complete chromatin immunoprecipitation assay design.

Chromatin Immunoprecipitation (ChIP) assays are commonly used to study protein-DNA interactions, however they often require long, complicated, and labor-intensive protocols. Our new ChromataChIP^TM kits contain everything you need to perform a highly efficient and simple Chromatin Immunoprecipitation in your lab.

Novus’ new Mix-and-Match Pathway Assay Kits allow for the simultaneous detection of activation states of multiple kinases in a signal pathway on a single multiwell platform. Our kits are designed to be much easier and faster than traditional Western blots (2.5 hour protocol), demonstrate a significantly greater dynamic range and sensitivity, operate with much less sample (5-20 micrograms total protein), and are more cost-effective with up to six data points per assay.

Novus Biologicals announced today a new mouse monoclonal ABCG8 antibody.

Novus Biologicals announced today a new mouse monoclonal ABCG8 antibody.

ABCG8 is an ATP binding cassette family member which acts to exclude non-cholesterol sterol entry to the intestine, to promote excretion of cholesterol and sterols into bile, and to facilitate transport of sterols back into the intestinal lumen. Novus’ new ABCG8 antibody (Catalog Number NBP1-71706) is useful for highly specific Westerm blot, immunoprecipitation, and immunofluorescence staining on paraffin-embedded mouse samples.

Novus Biologicals announced today a new CD31 antibody (catalog number NBP1-71663) for the study of cancer, angiogenesis and stem cells. This PECAM1 antibody was made using SDIX Genomic Antibodies^TM (GAT^TM). 

Novus Biologicals announced today a new CD31 antibody (catalog number NBP1-71663) for the study of cancer, angiogenesis and stem cells. This PECAM1 antibody was made using SDIX Genomic Antibodies^TM (GAT^TM). 

Littleton, CO (June 8th, 2011) – Novus Biologicals, an international supplier of antibodies and antibody-related products to bioscience researchers, is proud to announce the opening of their second international office in Oakville, Ontario, Canada.  Novus' other offices include Novus Europe, which services Europe from Cambridge, United Kingdom, and the worldwide headquarters, based in Littleton, Colorado.

Novus Biologicals announced today a new TIE2 antibody (NBP1-69753) for use in angiogenesis and protein kinase research.  This TIE2 antibody was made using SDIX Genomic Antibody Technology^TM (GAT^TM).